| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.031 | 0.5 |